Skip to main content

Table 1 Clinical characteristics of women with primary ovarian insufficiency (POI) and controls

From: Characterization of a novel mutation V136L in bone morphogenetic protein 15 identified in a woman affected by POI

Characteristic

POI

(n = 18)

Controls

(n = 100)

Luteinizing hormone (mU/mL)

41,3 ± 18,9

9,4 ± 7,2

Follicle stimulating hormone (mU/mL)

94,8 ± 40,8

6,3 ± 2,4

Estradiol (pg/mL)

26,7 ± 15,9

68,5 ± 43,1